APA

Chekenya M., Enger P. Ø., Thorsen F., Tysnes B. B., Al-Sarraj S., Read T. A., Furmanek T., Mahesparan R., Levine J. M., Butt A. M., Pilkington G. J. & Bjerkvig R. (20030312). The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. : Neuropathology and applied neurobiology.

Chicago

Chekenya M, Enger P Ø, Thorsen F, Tysnes B B, Al-Sarraj S, Read T A, Furmanek T, Mahesparan R, Levine J M, Butt A M, Pilkington G J and Bjerkvig R. 20030312. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. : Neuropathology and applied neurobiology.

Harvard

Chekenya M., Enger P. Ø., Thorsen F., Tysnes B. B., Al-Sarraj S., Read T. A., Furmanek T., Mahesparan R., Levine J. M., Butt A. M., Pilkington G. J. and Bjerkvig R. (20030312). The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. : Neuropathology and applied neurobiology.

MLA

Chekenya M, Enger P Ø, Thorsen F, Tysnes B B, Al-Sarraj S, Read T A, Furmanek T, Mahesparan R, Levine J M, Butt A M, Pilkington G J and Bjerkvig R. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. : Neuropathology and applied neurobiology. 20030312.